Role of mast cells and their mediators in failing myocardium under mechanical ventricular support

Journal of Heart and Lung Transplantation

Volumn 23, Issue 6, 2004, Pages 709-715

  Akgul, Ahmet ^a   Skrabal, Christian A ^a   Thompson, Larry O ^a   Loebe, Matthias ^a   Lafuente, Javier A ^a   Noon, George P ^a   Youker, Keith A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHYMASE; TRYPTASE;

ADULT; ARTICLE; CARDIOMYOPATHY; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE REMOVAL; FLUORESCENCE MICROSCOPY; HEART ASSIST DEVICE; HEART FAILURE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMPLANTATION; INSTRUMENTATION; MALE; MAST CELL; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE; TISSUE SECTION; WESTERN BLOTTING;

ADULT; CASE-CONTROL STUDIES; CELL COUNT; EXTRACELLULAR SPACE; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; MALE; MAST CELLS; MIDDLE AGED; MYOCARDIUM; TIME FACTORS;

EID: 1842836188     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.06.006     Document Type: Article

References (35)

1. Levin H.R., Oz M.C., Chen J.M., Packer M., Rose E.A., Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 91:1995;2717-2720
2. Mann D.L., Willerson J.T. Left ventricular assist devices and the failing heart A bridge to recovery, a permanent assist device, or a bridge too far? Circulation. 98:1998;2367-2369
3. Muller J., Wallukat G., Weng Y.G., et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 96:1997;542-549
4. Bruckner B.A., Stetson S.J., Perez-Verdia A., et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant. 20:2001;457-464
5. Artuc M., Hermes B., Steckelings U.M., Grutzkau A., Henz B.M. Mast cells and their mediators in cutaneous wound healing - active participants or innocent bystanders? Exp Dermatol. 8:1999;1-16
6. Bairoch A., Apweiler R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res. 28:2000;45-48
7. Irani A.A., Schechter N.M., Craig S.S., DeBlois G., Schwartz L.B. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U.S.A. 83:1986;4464-4468
8. Irani A.M., Schwartz L.B. Human mast cell heterogeneity. Allergy Proc. 15:1994;303-308
9. de Almeida A., Mustin D., Forman M.F., Brower G.L., Janicki J.S., Carver W. Effects of mast cells on the behavior of isolated heart fibroblasts Modulation of collagen remodeling and gene expression. J Cell Physiol. 191:2002;51-59
10. Gruber B.L., Kew R.R., Jelaska A., et al. Human mast cells activate fibroblasts Tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol. 158:1997;2310-2317
11. Brower G.L., Chancey A.L., Thanigaraj S., Matsubara B.B., Janicki J.S. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol. 283:2002;H518-H525
12. Kofford M.W., Schwartz L.B., Schechter N.M., Yager D.R., Diegelmann R.F., Graham M.F. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem. 272:1997;7127-7131
13. Walgenbach K.J., Gorospe J.R., Gratas C., Brunagel G., Hoffman E.P., Shestak K.C. A Potential Role for Mast Cells in the of bFGF From Normal Myocytes During Angiogenesis In Vivo. J Invest Surg. 15:2002;153-162
14. Patella V., Marino I., Arbustini E., et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation. 97:1998;971-978
15. Swan H.J. Left ventricular dysfunction in ischemic heart disease Fundamental importance of the fibrous matrix. Cardiovasc Drugs Ther. 8:(Suppl 2):1994;305-312
16. Weber K.T., Brilla C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 83:1991;1849-1865
17. Bruckner B.A., Stetson S.J., Farmer J.A., et al. The implications for cardiac recovery of left ventricular support on myocardial collagen content. Am J Surg. 180:2000;498-501
18. Galli S.J. New concepts about the mast cell. N Engl J Med. 328:1993;257-265
19. Artuc M., Steckelings U.M., Henz B.M. Mast cell-fibroblast interactions Human mast cells as source and inducers of fibroblast and epithelial growth factors. J Invest Dermatol. 118:2002;391-395
20. Kondo S., Kagami S., Kido H., Strutz F., Muller G.A., Kuroda Y. Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol. 12:2001;1668-1676
21. Caughey G.H. Serine proteinases of mast cell and leukocyte granules. A league of their own. Am J Respir Crit Care Med. 150:1994;S138-S142
22. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol. 61:1997;233-245
23. Caughey G.H., Raymond W.W., Wolters P.J. Angiotensin II generation by mast cell alpha- and beta- chymases. Biochim Biophys Acta. 1480:2000;245-257
24. Chandrasekharan U.M., Sanker S., Glynias M.J., Karnik S.S., Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science. 271:1996;502-505
25. Bernasconi P., Di Blasi C., Mora M., et al. Transforming growth factor-beta 1 and fibrosis in congenital muscular dystrophies. Neuromuscul Disord. 9:1999;28-33
26. Saarinen J., Kalkkinen N., Welgus H.G., Kovanen P.T. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem. 269:1994;18134-18140
27. Frank B.T., Rossall J.C., Caughey G.H., Fang K.C. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase. J Immunol. 166:2001;2783-2792
28. Qu Z., Liebler J.M., Powers M.R., et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol. 147:1995;564-573
29. Sciler G., Welle M., Busato A., Lin S., Gaschen F. Mast cell proliferation and alterations in bFGF amount and localization are involved in the response of muscle to dystrophin deficiency in hypertrophic feline dystrophy. Neuromuscul Disord. 11:2001;56-71
30. Craig S.S., Schechter N.M., Schwartz L.B. Ultrastructural analysis of maturing human T and TC mast cells in situ. Lab Invest. 60:1989;147-157
31. Goldstein S.M., Leong J., Schwartz L.B., Cooke D. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. J Immunol. 148:1992;2475-2482
32. Hetzer R., Muller J.H., Weng Y., Meyer R., Dandel M. Bridging-to- recovery. Ann Thorac Surg. 71:2001;S109-S113
33. Hetzer R., Muller J.H., Weng Y.G., Loebe M., Wallukat G. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy. J Thorac Cardiovasc Surg. 120:2000;843-853
34. Loebe M., Hennig E., Muller J., Spiegelsberger S., Weng Y., Hetzer R. Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement. Eur J Cardiothorac Surg. 11:(Suppl):1997;S18-S24
35. Scheinin S.A., Capek P., Radovancevic B., Duncan J.M., McAllister H.A. Jr., Frazier O.H. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J. 38:1992;M271-M274